FDA Recalls Dry Eye Relief Drops Nationwide Due to Non-Sterility
The FDA has issued a Class I recall of Dry Eye Relief eye drops sold nationwide due to non-sterility concerns. The manufacturer, Kilitch Healthcare India Limited, initiated the voluntary recall affecting 12,960 bottles.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I recalls carry a minimum severity score of 4 per the rubric. Non-sterility in an ophthalmic product poses significant risk of contamination and serious eye infection.
Plain-English summary
Dry Eye Relief eye drops containing Polyethylene glycol 400 0.4% and Propylene glycol 0.3% are being recalled. The product is sold in 0.33 FL OZ (10 mL) bottles under the Leader brand and distributed by Cardinal Health (NDC 70000-0088-1) nationwide within the United States. The recall involves 12,960 bottles and affects all lots of the product.
The manufacturer, Kilitch Healthcare India Limited, initiated this voluntary recall beginning November 13, 2023, due to non-sterility. The FDA classified this as a Class I recall on February 5, 2024.
This recall affects all consumers who obtained the product nationwide within the United States.
The recalled product
- Product
- DRY EYE RELIEF (POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL)
- Brand
- DRY EYE RELIEF
- Manufacturer
- Kilitch Healthcare India Limited
- Category
- Drug — Ophthalmic / Eye Drops
- Hazard
- non-sterility
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · DRY EYE RELIEF
- CriticalDrug recall: DRY EYE RELIEF eye drops for non-sterility
FDA (Drugs) · 2024-02-14
- SevereEye drops recalled for non-sterility due to bacterial contamination
FDA (Drugs) · 2023-11-29
- CriticalFDA Recalls Non-Sterile Dry Eye Relief Drops Due to Bacterial Contamination
FDA (Drugs) · 2023-11-29
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27